Neuberger Berman Group LLC Clovis Oncology, Inc. Transaction History

Neuberger Berman Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $204,960 - $410,720	-16,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $282,560 - $484,480	16,000 New	16,000 $397,000
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $687,434 - $1.16 Million	-23,406 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $984,456 - $1.46 Million	23,406 New	23,406 $1.06 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $634,590 - $930,380	-11,000 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $738,870 - $932,910	11,000	11,000 $906,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.